A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study,  published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis  […] Continue reading ->
European countries are experiencing soaring COVID-19 infection and death rates. With a third wave sweeping across Europe, hospitals are at risk of becoming overwhelmed and governments are facing increasing public opposition to continued lockdowns and social distancing restrictions. The WHO European Region, which includes 53 member states, has recorded an upward trend in cases for […] Continue reading ->
A new study published by a consortium of UK-based airline industry interests suggested that administration to travelers of a rapid antigen test upon arrival at their destination, may be just as effective as quarantine requirements, to stop imports of COVID-19 cases. The study, which reviewed case studies of airport testing procedures elsewhere, claims that a […] Continue reading ->
A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading ->
British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday.  The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US  Data Safety and Monitoring Board (DSMB) to review the […] Continue reading ->
Previous infection with COVID-19 protects most people against reinfection for over six months, but those over the age of 65 are more likely to get infected again, found a peer reviewed study published in The Lancet.  In the world’s first large-scale study of COVID-19 reinfections, researchers from Denmark, Sweden and the United Kingdom discovered that […] Continue reading ->